Department of Symptom Research, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
J Pain Symptom Manage. 2013 Dec;46(6):837-45. doi: 10.1016/j.jpainsymman.2013.02.007. Epub 2013 Apr 22.
Experts in patient-reported outcome (PRO) measurement emphasize the importance of including patient input in the development of PRO measures. Although best methods for acquiring this input are not yet identified, patient input early in instrument development ensures that instrument content captures information most important and relevant to patients in understandable terms.
The M. D. Anderson Symptom Inventory (MDASI) is a reliable valid PRO instrument for assessing cancer symptom burden. We report a qualitative (open-ended, in-depth) interviewing method that can be used to incorporate patient input into PRO symptom measure development, with our experience in constructing an MDASI module for ovarian cancer (MDASI-OC) as a model.
Fourteen patients with ovarian cancer (OC) described symptoms experienced at the time of the study, at diagnosis, and during prior treatments. Researchers and clinicians used content analysis of interview transcripts to identify symptoms in patient language. Symptoms were ranked on the basis of the number of patients mentioning them and by clinician assessment of relevance.
Forty-two symptoms were mentioned. Eight OC-specific items will be added to the 13 core symptom items and six interference items of the MDASI in a test version of the MDASI-OC on the basis of the number of patients mentioning them and clinician assessment of importance. The test version is undergoing psychometric evaluation.
The qualitative interviewing process, used to develop the test MDASI-OC, systematically captures common symptoms important to patients with OC. This methodology incorporates the patient experience recommended by experts in PRO instrument development.
在患者报告结局(PRO)测量方面的专家强调在开发 PRO 测量工具时纳入患者意见的重要性。虽然尚未确定获取这些意见的最佳方法,但在仪器开发早期纳入患者意见可确保仪器内容以可理解的术语来捕获对患者最重要和最相关的信息。
M.D.安德森症状指数(MDASI)是一种可靠有效的 PRO 工具,用于评估癌症症状负担。我们报告了一种定性(开放式、深入)访谈方法,可用于将患者意见纳入 PRO 症状测量工具的开发中,以我们构建卵巢癌 MDASI 模块(MDASI-OC)的经验为模型。
14 名卵巢癌(OC)患者描述了研究时、诊断时和之前治疗期间经历的症状。研究人员和临床医生使用访谈记录的内容分析来识别患者语言中的症状。根据患者提及的次数和临床医生对相关性的评估,对症状进行排名。
共提到了 42 个症状。根据患者提及的次数和临床医生对重要性的评估,将在 MDASI 的 13 个核心症状项目和 6 个干扰项目的基础上,在 MDASI-OC 的测试版本中增加 8 个 OC 特异性项目。该测试版本正在进行心理测量评估。
用于开发测试 MDASI-OC 的定性访谈过程系统地捕捉了对 OC 患者重要的常见症状。该方法纳入了 PRO 仪器开发专家推荐的患者体验。